Anticonvulsant action of allopregnanolone in immature rats

Epilepsy Research

Volumn 70, Issue 2-3, 2006, Pages 110-117

  Mares P ^a   Mikulecka A ^a   Haugvicova R ^a   Kasal, A ^b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Allopregnanolone; Convulsions; Ontogeny; Pentetrazol; Rat

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; NEUROSTEROID; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL ANIMAL; GRAND MAL EPILEPSY; IMMATURITY; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TASK PERFORMANCE;

EID: 33746917578     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.03.009     Document Type: Article

References (34)

1. A receptors. J. Physiol. (Lond.) 558 (2004) 59-74
2. Altman J., and Sudarshan K. Postnatal development of locomotion in the laboratory rat. Anim. Behav. 23 (1975) 896-920
3. A receptor. Nat. Rev. Neurosci. 6 (2005) 565-575
4. Belelli D., Bolger M.B., and Gee K.W. Anticonvulsant profile of the progesteron metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166 (1989) 325-329
5. Bolles R.C., and Woods P.S. The ontogeny of behavior in the albino rat. Anim. Behav. 12 (1964) 427-441
6. A receptor. J. Pharmacol. Exp. Ther. 280 (1997) 1284-1295
7. Compagnone N.A., and Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21 (2000) 1-56
8. A IPSCs during development in rat hippocampal or cerebellar slices. J. Physiol. (Lond.) 521 (1999) 437-449
9. Frye C.A. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696 (1995) 113-120
10. Frye C.A., and Scalise T.J. Antiseizure effects of progesterone and 3α,5α-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25 (2000) 407-420
11. Gasior M., Carter R.B., Goldberg S.R., and Witkin J.M. Anticonvulsant and behavioural effects of neuroactive steroids alone and in conjunction with diazepam. J. Pharmacol. Exp. Ther. 282 (1997) 543-553
12. Gasior M., Carter R.B., and Witkin J.M. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol. Sci. 20 (1999) 107-112
13. Haugvicová R., Škutová M., Kubová H., Suchomelová L., and Mareš P. Two different anticonvulsant actions of tiagabine in developing rats. Epilepsia 41 (2000) 1375-1381
14. Haugvicová R., Kubová H., and Mareš P. Does vigabatrin possess an anticonvulsant action against pentylenetetrazol-induced seizures in developing rats?. Physiol. Res. 51 (2002) 363-370
15. Hauser A. Incidence and prevalence. In: Engel Jr. J., and Pedley T.A. (Eds). Epilepsy. A Comprehensive Textbook (1998), Lippincott-Raven, Philadelphia 47-57
16. A receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 45 (2004) 864-867
17. Kokate T.G., Svensson B.E., and Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 270 (1994) 1223-1229
18. Kokate T.G., Cohen A.L., Karp E., and Rogawski M.A. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35 (1996) 1049-1056
19. Kubová H., and Mareš P. Anticonvulsant effects of phenobarbital and primidone during ontogenesis in rats. Epilepsy Res. 10 (1991) 148-155
20. Kubová H., and Mareš P. The effect of ontogenetic development on the anticonvulsant activity of midazolam. Life Sci. 50 (1992) 1665-1672
21. A receptors. Prog. Neurobiol. 71 (2003) 67-80
22. Liptáková S., Velíšek L., Velíšková J., and Moshé S.L. Effect of ganaxolone on flurothyl seizures in developing rats. Epilepsia 41 (2000) 788-793
23. Löscher W., Honack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
24. Löscher W., and Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2 (1988) 95-134
25. Mareš P. Anticonvulsant action of three neurosteroids against cortical epileptic afterdischarges in immature rats. Brain Res. Bull. 68 (2005) 179-184
26. Mareš P., and Zouhar A. Do we possess adequate models of childhood epilepsies?. Physiol. Bohemoslov. 37 (1988) 1-9
27. Mareš P., Marešová D., and Schickerová R. Effect of antiepileptic drugs on metrazol convulsions during ontogenesis in the rat. Physiol. Bohemoslov. 30 (1981) 113-121
28. Mareš P., Folbergrová H., and Kubová H. Excitatory aminoacids and epileptic seizures in immature brain. Physiol. Res. 53 Suppl. 1 (2004) S115-S124
29. Mareš, P., Haugvicová, R., Kasal, A., in press. Action of two neuroactive steroids against motor seizures induced by pentetrazol in rats during ontogeny. Physiol. Res.
30. Mikulecká A., and Mareš P. NMDA receptor antagonists impair motor performance in immature rats. Psychopharmacology 162 (2002) 364-372
31. Pohl M., and Mareš P. Effects of flunarizine on metrazol-induced seizures in developing rats. Epilepsy Res. 1 (1987) 302-305
32. Reddy D.S., and Rogawski M.A. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 42 (2001) 337-344
33. Velíšek L., Kubová H., Pohl M., Staňková L., Mareš P., and Schickerová R. Pentylenetetrazol-induced seizures in rats: an ontogenetic study. Naunyn-Schmiedeberg's Arch. Pharmacol. 346 (1992) 588-591
34. Wieland S., Belluzzi J.D., Stein L., and Lan N.C. Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents. Psychopharmacology 118 (1995) 65-71